The Lab of the Future: Barriers to Digital Transformation in the Life Sciences Industry
Experts predict over the next two years, life sciences companies will invest over $3 billion in AI, with two-thirds adopting the "intelligent lab of the future" within four years.
Taking a digital-first approach has become a strategic imperative in the pharmaceutical and biopharma industries. Yet many life sciences companies, big and small, are early in their digital transformation journeys or not yet gleaning value from their existing investments.
Enthought has been digitally transforming R&D for leading, global science-driven companies for over 20 years. We're providing this eBook to help guide your lab's transformation initiatives.
Download “The Lab of the Future: Five Barriers to Digital Transformation in the Life Sciences Industry” to learn:
- How current industry-specific market trends and pressures are impacting decisions
- The common barriers to successful digital transformation in life sciences
- Recommendations on what can be done now to attain the future-proofed R&D lab
Questions? Contact info@enthought.com to discuss how the Enthought Materials Science and Chemistry Solutions Group can help future-proof your R&D lab and accelerate your business.
Download eBook
Related Content
Enthoughtが定義する、製薬会社の研究開発ラボにおける真のDX
Enthought GKチームは、東京で開催されたライフサイエンスカンファレンス「ファーマIT&デジタルヘルスエキスポ2022」に出展し、技術的な見識と市場成長の活性化を求めて集まる製薬業界のリーダーたちと会談しました。三日間の会期中に200社が出展し、6700人以上の参加者が集まりました。 デジタルトランスフォーメーションが主要テーマである本展示会は、当社のターゲットとする企業に、製薬業界の新薬開発を加速させる当社のサービスを
Life Sciences Labs Optimize with New Digital Technologies and Upskilling
Labs are resetting the tr…
Join Our Mailing List!
Sign up below to receive email updates including the latest news, insights, and case studies from our team.